Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.540
-0.040 (-2.53%)
Oct 23, 2025, 2:01 PM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Oncology Therapies
7.00M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
7.00M